Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia-Reference-Cited by-同舟云学术

Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia

Published:2013-10-17 Issue:16 Volume:122 Page:2807-2811
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Takahashi Koichi¹²,Pemmaraju Naveen³,Strati Paolo³,Nogueras-Gonzalez Graciela⁴,Ning Jing⁴,Bueso-Ramos Carlos⁵,Luthra Rajyalakshmi⁵,Pierce Sherry³,Cortes Jorge³,Kantarjian Hagop³,Garcia-Manero Guillermo³

Affiliation:

1. Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX;

2. Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; and

3. Department of Leukemia,

4. Department of Biostatistics, and

5. Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX

Abstract

Key Points t-CMML is associated with higher-risk cytogenetics and manifests poor prognosis. t-CMML should be recognized as one of the therapy-related myeloid neoplasms.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/122/16/2807/1369281/2807.pdf

Reference14 articles.

1. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia.;Bennett;Br J Haematol,1994

2. Therapy related CMML: a case report and review of the literature.;Ahmed;Int J Hematol,2009

3. Secondary myelodysplastic syndromes following treatment with azathioprine are associated with aberrations of chromosome 7.;Knipp;Haematologica,2005

4. Three cases of multiple myeloma developing into melphalan-related chronic myelomonocytic leukemia.;Ueki;J Med,1991

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management;American Journal of Hematology;2024-03-07

3. Updates in molecular genetics of therapy-related myeloid neoplasms;Seminars in Diagnostic Pathology;2023-05

4. Risks of therapy-related hematologic neoplasms beyond myelodysplastic syndromes and acute myeloid leukemia;Blood;2023-02-23

5. Inherited heterozygous Fanconi anemia gene mutations in a therapy-related CMML patient with a rare NUP98-HOXC11 fusion: A case report;Frontiers in Oncology;2022-10-19